What Is Autologous Haematopoietic Stem Cell Transplant?
An autologous haematopoietic stem cell transplant, also called an autologous bone marrow transplant or autologous stem cell transplant, is a treatment that uses your own blood stem cells to help your body recover after receiving very high doses of chemotherapy or radiation. The word “autologous” means that the stem cells come from your own body, not from another person.[1][5]
Your bone marrow is the soft, spongy tissue inside your bones where blood cells are made. Blood stem cells are special cells that can grow into all types of blood cells your body needs, including red blood cells that carry oxygen, white blood cells that fight infection, and platelets that help blood clot. When chemotherapy or radiation is strong enough to kill cancer cells, it can also damage healthy bone marrow and stop it from making these important blood cells. The transplant replaces damaged bone marrow with healthy stem cells so your body can start producing blood cells again.[5][6]
Using your own stem cells has certain advantages compared to using cells from a donor. You don’t have to worry about whether the cells will be compatible with your body, and you avoid some complications that can happen when donor cells are used. However, this type of transplant is only possible if your body is producing enough healthy stem cells that can be collected and stored before you begin intensive treatment.[1][8]
Epidemiology
Autologous haematopoietic stem cell transplantation has become increasingly common over the past several decades. Worldwide, approximately 90,000 first-time stem cell transplants are performed each year. Of these, about 53 percent are autologous transplants, meaning patients receive their own stem cells rather than cells from a donor.[6]
The number of transplants continues to grow each year. Statistics show that the use of this procedure has been increasing by 10 to 20 percent annually. This steady rise reflects both improved transplant techniques and expanding knowledge about which patients might benefit from this treatment approach.[6]
More than half of all autologous transplants are performed to treat two specific blood cancers: multiple myeloma and non-Hodgkin lymphoma. Multiple myeloma, a cancer affecting plasma cells in the bone marrow, is the most common reason doctors recommend autologous stem cell transplantation as an initial treatment.[6][5]
Causes and Indications
Autologous haematopoietic stem cell transplant is not used to treat the original cause of a disease, but rather to address the damage caused by intensive cancer treatments. The underlying diseases being treated are typically blood cancers or severe autoimmune conditions that have not responded to other therapies.[2]
The procedure is most commonly recommended for people with multiple myeloma, a condition where cancerous plasma cells multiply in the bone marrow and produce abnormal proteins. Healthcare providers often use autologous transplant as the first-line treatment for this disease, meaning it may be recommended early in the treatment plan.[5]
This transplant may also be an option for people with Hodgkin lymphoma or non-Hodgkin lymphoma when other treatments have not worked or when the cancer comes back after previous treatment. Doctors describe cancer that doesn’t respond to treatment as refractory cancer, and cancer that returns after a period of improvement as recurrent cancer. In these situations, autologous transplant offers another treatment possibility.[5]
Beyond blood cancers, autologous haematopoietic stem cell transplantation is increasingly being used to treat severe autoimmune and inflammatory diseases that resist conventional treatments. Autoimmune diseases occur when the body’s immune system mistakenly attacks its own tissues. When these conditions are severe and don’t improve with standard medications, a stem cell transplant may help reset the immune system.[2][9]
Treatment-resistant germ cell tumors are another indication for this procedure, though this is less common. Additionally, some patients with certain autoimmune conditions in treatment-resistant settings may be considered for autologous transplants.[5]
Risk Factors
Not everyone with blood cancer or autoimmune disease is a candidate for autologous stem cell transplant. Whether this treatment is appropriate depends on several factors related to a patient’s overall health and the characteristics of their disease.
The first requirement is that the patient’s body must be producing enough healthy stem cells. These cells need to be collected before the intensive chemotherapy or radiation begins. If the disease has severely damaged the bone marrow or if previous treatments have affected stem cell production, collecting enough healthy cells may not be possible.[1]
A person’s overall health apart from their cancer or autoimmune condition plays a major role in determining whether they can safely undergo this procedure. High-dose chemotherapy and radiation can cause significant side effects and put stress on the heart, lungs, liver, and kidneys. People with existing problems in these organs may face higher risks during and after transplant.[5]
Age can be a consideration, though it’s not an absolute barrier. Older adults may have more difficulty tolerating the intensive treatment regimen and may take longer to recover. However, decisions are made on an individual basis, considering each person’s specific health status rather than age alone.
The intensity of the treatment also increases the risk of serious infections. During the period after transplant, when the bone marrow is recovering, the body’s ability to fight off bacteria, viruses, and fungi is significantly reduced. This makes patients vulnerable to infections that healthy immune systems would normally handle easily.[5]
Symptoms and Effects
Autologous haematopoietic stem cell transplant itself is a treatment procedure rather than a disease, so it doesn’t have symptoms in the traditional sense. However, the process creates temporary but significant effects on the body that patients need to understand and prepare for.
During the conditioning phase, which typically lasts 7 to 14 days, patients receive high doses of chemotherapy and possibly radiation. This intensive treatment is designed to kill cancer cells, but it also causes side effects. Patients commonly experience severe fatigue, nausea, vomiting, and loss of appetite. These symptoms can make eating difficult, even though proper nutrition is important for recovery.[6]
The chemotherapy and radiation damage the lining of the digestive system, often causing painful mouth sores and inflammation. Some patients develop diarrhea or constipation. Hair loss is common with high-dose chemotherapy, though hair typically grows back several months after treatment ends.[5]
After the stem cells are infused back into the body, patients enter what doctors call the neutropenic phase. During this period, which can last several weeks, the bone marrow is not producing enough white blood cells to fight infections. Patients become extremely vulnerable to bacteria, viruses, and fungi. Even minor infections can quickly become serious or life-threatening during this time.[6]
The period before the new stem cells begin producing blood cells is called the engraftment phase. Until engraftment occurs, patients may need frequent blood transfusions to replace red blood cells and platelets. They may feel weak, short of breath, and tire easily due to low red blood cell counts. Low platelet counts increase the risk of bleeding and bruising.[6]
Feeling extremely tired is one of the most challenging and long-lasting effects after transplant. This fatigue is not like ordinary tiredness and doesn’t improve with rest alone. It can persist for many months, affecting some people more than others. Recovery of energy and strength is gradual and requires patience.[12][20]
Prevention
Because autologous stem cell transplant is a treatment for existing conditions rather than a disease itself, prevention focuses on reducing complications and supporting the best possible outcomes during and after the procedure.
Preventing infection is the highest priority throughout the transplant process. Before the procedure begins, patients may receive a central venous catheter, a tube placed in a large vein in the chest. This device allows medical staff to give medications, draw blood, and infuse stem cells without repeated needle sticks. Proper care of this catheter is essential to prevent infections from entering the bloodstream.[5]
Patients receive medications to prevent specific types of infections during their hospital stay and for weeks or months afterward. These preventive medicines typically include antibiotics to guard against bacteria, antiviral drugs to protect against viruses, and antifungal medications to prevent fungal infections. Taking these medications exactly as prescribed is crucial for staying healthy during the vulnerable recovery period.[6]
The home environment requires careful attention to reduce infection risk. For the first 100 days after the stem cell infusion, patients should limit visitors and avoid contact with anyone who is sick or has a respiratory illness. Daily cleaning of bathrooms and regular household cleaning help prevent the growth of bacteria, mold, and mildew. However, patients should not do the cleaning themselves, as this could expose them to germs or irritating chemicals.[16]
Live plants should be removed from rooms where patients spend time, as soil can harbor fungi and bacteria. Pets can provide comfort, but patients should not handle pet waste or clean litter boxes. Someone else should take on these tasks to minimize infection risk.[16]
Nutrition plays an important role in supporting recovery, though eating can be difficult when side effects affect appetite and digestion. Working with a nutritionist who understands the special needs of transplant patients can help ensure adequate nutrition even when eating is challenging. Some foods that are normally healthy, such as raw fruits and vegetables, may need to be avoided temporarily because they could carry bacteria.[21]
Physical activity, even in small amounts, helps maintain strength and promotes recovery. However, patients need to balance activity with rest and follow their healthcare team’s guidance about what is safe and appropriate at different stages of recovery.[12]
Pathophysiology
Understanding how autologous haematopoietic stem cell transplant affects the body helps explain why this treatment is necessary and what happens at each stage.
The process begins with mobilization of stem cells. Normally, most haematopoietic stem cells stay in the bone marrow. To collect enough cells for transplant, patients receive growth factor drugs—hormone-like substances that stimulate the bone marrow to produce more stem cells. Additional medications help move these cells from the bone marrow into the bloodstream, a process called mobilization.[5]
Stem cell collection, also called harvesting or apheresis, involves a machine that filters stem cells from the blood. Blood is drawn from a vein in one arm, flows through a cell separator machine that removes stem cells, and then returns to the body through a vein in the other arm. This process doesn’t hurt but can take three to four hours, and may need to be repeated to collect enough cells. The collected stem cells are then frozen and stored until needed.[5][12]
The conditioning regimen that follows is designed to accomplish several goals. In cancer treatment, it aims to kill any remaining cancer cells. The intensive chemotherapy and radiation also clear space in the bone marrow for the new stem cells to establish themselves. However, this same treatment severely damages or destroys the bone marrow’s ability to produce blood cells, which is why the transplant is necessary.[6]
After conditioning is complete, the stored stem cells are thawed and infused back into the patient through an intravenous line. The infusion itself is relatively simple and similar to receiving a blood transfusion. The stem cells travel through the bloodstream and naturally find their way back to the bone marrow, where they begin to settle and establish themselves.[5]
The critical period that follows is when the new stem cells must engraft, or begin growing and producing new blood cells. Engraftment typically takes two to three weeks but can take longer. During this time, blood cell counts remain very low, leaving patients vulnerable to infection, bleeding, and anemia. Once engraftment occurs, blood counts gradually begin to rise, though full recovery of the immune system can take many months.[6][20]
The body’s recovery after transplant is not immediate or linear. It may take a year or longer for patients to feel they are truly recovering. Energy levels improve slowly, immune function gradually strengthens, and side effects gradually resolve. Regular follow-up appointments help doctors monitor this recovery process and address any complications that arise.[12][20]
